Blood Pressure Check At Barbershop Benefits African-American Males

African-American males who can have their blood pressure gauged at their local barbershop have a significantly higher chance of better hypertension (high blood pressure) control, researchers reveal in Archives of Internal Medicine. High blood pressure, or hypertension is a condition in which blood pressure in the arteries is chronically high…

Study Investigates Variability In Men’s Recall Of Sexual Cues

Even if a woman is perfectly clear in expressing sexual interest or rejection, young men vary in their ability to remember the cues, a new University of Iowa study shows. Overall, college-age men were quite good at recalling whether their female peers in this case, represented through photos showed interest…

Gel Alternative To Contraceptive Pill Shows Promising Results In Small Trial

A gel alternative to the contraceptive pill that women may only have to rub into the skin every day to prevent ovulation has shown promising results in a small phase 2 clinical trial reported at a conference in the US this week…

Put Doctors on Salary, Survey Says

(MedPage Today) — The healthcare system would be much improved if physicians were all on salary, according to results from a survey by the Commonwealth Fund.

IDSA: Frogs for Kids Come With Salmonella (CME/CE)

VANCOUVER (MedPage Today) — African dwarf frogs — marketed as pets for kids and people with major illnesses — appear to be the vector for a major Salmonella typhimurium outbreak that sickened 113 people in 31 states over the course of a year.

Docs Unhappy With Medicare, But Can’t Agree on a Fix (CME/CE)

(MedPage Today) — Most physicians believe current Medicare payments are unfair, but there is little consensus among doctors on how to make payments more equitable, according to a new study.

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals reported today the randomization of the last patient in its short-term study component of its Phase 3 registration program of Zerenex™ (ferric citrate), the Company’s iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

Purdue and Mundipharma assume worldwide development for Infinity’s fatty acid amide hydrolase program

Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity’s fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity’s oral FAAH inhibitor, IPI-940.

Agile presents AG200-15 contraceptive patch Phase 2 clinical study results at 66th ASRM

Agile Therapeutics announced results today from a Phase 2 clinical study of AG200-15, Agile’s weekly contraceptive patch containing ethinyl estradiol (EE) in combination with levonorgestrel (LNG). According to the clinical findings, AG200-15 provides a low daily dose of estrogen equivalent to 30 micrograms EE, similar to that in low-dose, oral contraceptive (OC) pills.

TransPharma announces positive results of ViaDerm-hPTH Phase 1 trial for osteoporosis treatment

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.